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Black-curranl (Ribes nigrum L.) leaves are traditionally used in Europe for thé treatment of
rheumatic disease. The anti-inflammatory activity (in carrageenan-induced rat paw-oedema)
is mainly due to prodelphinidins [1J
Another articular disease, osteoarthritis, is thé clinica] expression of thé loss of cartilage
function. COX inhibitors are widely used in thé treatment of such pathologies for their
bénéficiai effects on inflammation but often produce a négative activity on cartilage
synthesis.
In this study, we determined thé effect of différent prodelphinidins isolated from Ribes
nigrum leaves, on thé proteoglycans, type II collagen and prostaglandin E2 productions by
differentiated human chondrocytes cultivated in long term (12 days) and in clusters as well
as their inhibition potential on COX-1 and COX-2 in vitro [2, 3]. Gallocatechin trimer (GC-
GC-GC) showed thé higher stimulation of PGs and coll. II production (1 ug ml"1) and thé
synthesis of PGE2 was significantly reduced by gallocatechin dimer (GC-GC), gallocatechin-
epigallocatechin (GC-EGC) and GC-GC-GC at 10 and 100 ug ml"1. The inhibition of PGE2
synthesis was confirmed by thé in vitro test on purified COX enzymes, showing thé
selectivity of prodelphinidins on COX-2 (see table ).
Our studies suggest lhat thé prodelphinidins fractions frorn R. nigrum may be useful as an
additive agent in thé prévention of osteoarthritis.
Indomethacin 10"
Nimesulide 10"4 M
GC, 10 4 M
GC, 10 5 M
GC, icr'M
GC-GC, 10 4 M
GC-GC, 10 s M
GC-GC, 10 " M
GC-EGC, 10 4 M






























*Results expressed as inhibi t ion percentage of PGE2 production
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